Bussel, James B

Publications

Sort by

Co-Author Network

selected publications

Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children. British journal of haematology. 2020 Letter GET IT
Times cited: 9
Long-term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP). British journal of haematology. 2020 Academic Article GET IT
Times cited: 2
Blood transcriptome and clonal T-cell correlates of response and non-response to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia. Haematologica. 2019 Letter GET IT
Times cited: 6
Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists. Platelets. 2019 Academic Article GET IT
Times cited: 6
FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiency. British journal of haematology. 2019 Letter GET IT
Times cited: 4
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?. Haematologica. 2019 Review GET IT
Times cited: 41
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia. American journal of hematology. 2019 Letter GET IT
Times cited: 4
Thrombopoietin receptor agonists: ten years later. Haematologica. 2019 Review GET IT
Times cited: 167
Response to thrombopoietic agents is related to on-treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia. American journal of hematology. 2019 Letter GET IT
Times cited: 3
Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy. 2019 GET IT
Times cited: 2
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. American journal of hematology. 2019 Academic Article GET IT
Times cited: 32
Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists. Platelets. 2019 Academic Article GET IT
Times cited: 15
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach. British journal of haematology. 2019 Academic Article GET IT
Times cited: 45
Peri- and Postpartum Management of Patients With Factor XI Deficiency. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2019 Academic Article GET IT
Times cited: 6
Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study. British journal of haematology. 2018 Academic Article GET IT
Times cited: 15
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study. American journal of hematology. 2018 Academic Article GET IT
Times cited: 17
Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Vox sanguinis. 2018 Academic Article GET IT
Times cited: 27
TPO-mimetics for chemotherapy-induced thrombocytopenia: timing matters. Leukemia & lymphoma. 2018 Comment GET IT
Times cited: 1
Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag. Science translational medicine. 2018 Academic Article GET IT
Times cited: 39
IVIg and FcγRIIb in kids with ITP: individualizing therapy. Blood. 2018 Comment GET IT
Times cited: 2
Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017. 2018 GET IT
Times cited: 17
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology (Oxford, England). 2018 Academic Article GET IT
Times cited: 30
Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms. British journal of haematology. 2018 Letter GET IT
Times cited: 9
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials. American journal of hematology. 2018 Academic Article GET IT
Times cited: 175
Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. American journal of hematology. 2018 Academic Article GET IT
Times cited: 25
Screening for Wiskott-Aldrich syndrome by flow cytometry. The Journal of allergy and clinical immunology. 2018 Letter GET IT
Times cited: 14
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia. Platelets. 2017 Academic Article GET IT
Times cited: 16
Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone. The Journal of pediatrics. 2017 Academic Article GET IT
Times cited: 20
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. Blood. 2017 Academic Article GET IT
Times cited: 173
Fostamatinib for persistent/chronic adult immune thrombocytopenia. Immunotherapy. 2017 Review GET IT
Times cited: 44
Imaging and management of fetuses and neonates with alloimmune thrombocytopenia. Pediatric blood & cancer. 2017 Review GET IT
Times cited: 6
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia. American journal of hematology. 2017 Academic Article GET IT
Times cited: 35
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. Haematologica. 2017 Academic Article GET IT
Times cited: 79
Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood. 2017 Review GET IT
Times cited: 76
Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2017 Academic Article GET IT
Times cited: 16
Immune thrombocytopenia: a need for assisted suicide. British journal of haematology. 2016 Editorial Article GET IT
Times cited: 1
Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP). Platelets. 2016 Academic Article GET IT
Times cited: 6
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia. Transfusion. 2016 Academic Article GET IT
Times cited: 6
Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia. American journal of hematology. 2016 Academic Article GET IT
Times cited: 32
Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia. American journal of obstetrics and gynecology. 2016 Academic Article GET IT
Times cited: 13
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Lancet (London, England). 2016 Academic Article GET IT
Times cited: 101
Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation. Haematologica. 2016 Letter GET IT
Times cited: 13
Hospitalizations in pediatric patients with immune thrombocytopenia in the United States. Platelets. 2016 Academic Article GET IT
Times cited: 10
What do we know about intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia?. Transfusion. 2016 Editorial Article GET IT
Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor. British journal of haematology. 2015 Letter GET IT
Times cited: 25
Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim. Hematology (Amsterdam, Netherlands). 2015 Academic Article GET IT
Times cited: 18
Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia. Blood. 2015 Academic Article GET IT
Times cited: 73
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet (London, England). 2015 Academic Article GET IT
Times cited: 150
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. The Lancet. Haematology. 2015 Academic Article GET IT
Times cited: 129
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia. PLoS genetics. 2015 Academic Article GET IT
Times cited: 113
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. Journal of thrombosis and haemostasis : JTH. 2015 Academic Article GET IT
Times cited: 18
Review of fetal and neonatal immune cytopenias. Clinical advances in hematology & oncology : H&O. 2015 Review GET IT
Times cited: 20
Thrombopoietin receptor agonists: a critical review. Seminars in hematology. 2014 Review GET IT
Times cited: 27
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP). Pediatric blood & cancer. 2014 Academic Article GET IT
Times cited: 54
IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens. Blood. 2014 Academic Article GET IT
Times cited: 44
The new thrombopoietic agenda: impact on leukemias and MDS. Best practice & research. Clinical haematology. 2014 Review GET IT
Times cited: 8
In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia. British journal of haematology. 2014 Academic Article GET IT
Times cited: 15
Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia. American journal of hematology. 2014 Academic Article GET IT
Times cited: 28
A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?. British journal of haematology. 2014 Academic Article GET IT
Times cited: 11
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. Blood. 2014 Academic Article GET IT
Times cited: 93
Management of thrombocytopenia. F1000prime reports. 2014 Review GET IT
Times cited: 402
Thrombopoietic agents for the treatment of persistent and chronic immune thrombocytopenia in children. The Journal of pediatrics. 2014 Academic Article GET IT
Times cited: 43
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Academic Article GET IT
Times cited: 100
Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia. British journal of haematology. 2014 Academic Article GET IT
Times cited: 80
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. Haematologica. 2014 Academic Article GET IT
Times cited: 60
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration. Haematologica. 2014 Academic Article GET IT
Times cited: 66
Primary thrombocytosis in children. Haematologica. 2014 Review GET IT
Times cited: 37
The coming of age of the megakaryocyte-platelet. British journal of haematology. 2014 Editorial Article GET IT
Thrombopoietic agents: there is still much to learn. Presse medicale (Paris, France : 1983). 2014 Review GET IT
Times cited: 10
Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up. Haematologica. 2014 Academic Article GET IT
Times cited: 70
Contemporary treatment of immune thrombocytopenia. Expert review of hematology. 2013 Review GET IT
Times cited: 4
ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013 Letter GET IT
Times cited: 124
Modified antibody in fetal alloimmunization. Blood. 2013 Comment GET IT
Times cited: 1
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. British journal of haematology. 2013 Academic Article GET IT
Times cited: 26
How low can you go?. Blood. 2013 Comment GET IT
Times cited: 3
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. British journal of haematology. 2013 Academic Article GET IT
Times cited: 197
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013 Conference Paper GET IT
Times cited: 153
Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP). British journal of haematology. 2012 Academic Article GET IT
Times cited: 53
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood. 2012 Academic Article GET IT
Times cited: 248
The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP). British journal of haematology. 2012 Academic Article GET IT
Times cited: 22
Thrombopoietin-receptor agonists. Current opinion in hematology. 2012 Review GET IT
Times cited: 33
CD16+ monocytes control T-cell subset development in immune thrombocytopenia. Blood. 2012 Academic Article GET IT
Times cited: 60
Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood. 2012 Academic Article GET IT
Times cited: 150
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. Journal of thrombosis and haemostasis : JTH. 2012 Academic Article GET IT
Times cited: 32
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists. British journal of haematology. 2012 Letter GET IT
Times cited: 22
Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. British journal of haematology. 2012 Academic Article GET IT
Times cited: 36
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012 Review GET IT
Times cited: 180
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood. 2012 Academic Article GET IT
Times cited: 257
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood. 2012 Academic Article GET IT
Times cited: 96
Avoiding intuxication. Blood. 2012 Comment GET IT
Times cited: 1
Abnormalities in IgA and IgM are associated with treatment-resistant ITP. Blood. 2012 Academic Article GET IT
Times cited: 11
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood. 2012 Academic Article GET IT
Times cited: 75
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nature immunology. 2011 Academic Article GET IT
Times cited: 547
Clinical trial opportunities in hemostasis and thrombosis: NHBLI State-of-the-Science symposium. American journal of hematology. 2011 Conference Paper GET IT
Times cited: 1
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity. Blood. 2011 Academic Article GET IT
Times cited: 46
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. Journal of thrombosis and haemostasis : JTH. 2011 Academic Article GET IT
Times cited: 100
Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstetrics and gynecology. 2011 Academic Article GET IT
Times cited: 82
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. British journal of haematology. 2011 Academic Article GET IT
Times cited: 107
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME). Transfusion. 2011 Review GET IT
Times cited: 49
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents. British journal of haematology. 2011 Academic Article GET IT
Times cited: 30
Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP). Pediatric blood & cancer. 2011 Academic Article GET IT
Times cited: 36
Consider thrombotic microangiopathy in pediatric and hematopoietic stem cell transplant patients. Oncology (Williston Park, N.Y.). 2011 Comment GET IT
Times cited: 1
Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2011 Academic Article GET IT
Times cited: 32
Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology (Amsterdam, Netherlands). 2011 Academic Article GET IT
Times cited: 13
Eltrombopag for chronic immune thrombocytopenia. Lancet (London, England). 2011 Letter GET IT
Times cited: 2
Antenatal interventions for fetomaternal alloimmune thrombocytopenia. The Cochrane database of systematic reviews. 2011 Review GET IT
Times cited: 32
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood. 2011 Academic Article GET IT
Times cited: 178
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011 Academic Article GET IT
Times cited: 118
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents. Circulation. 2011 Academic Article GET IT
Times cited: 21
Eltrombopag. Cancer treatment and research. 2011 Review GET IT
Times cited: 13
Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective. Haematologica. 2010 Editorial Article GET IT
Times cited: 28
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet (London, England). 2010 Academic Article GET IT
Times cited: 419
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood. 2010 Academic Article GET IT
Times cited: 228
Stability of measurement of the immature platelet fraction. American journal of hematology. 2010 Letter GET IT
Times cited: 23
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nature immunology. 2010 Academic Article GET IT
Times cited: 253
What do healthcare providers ask their patients with immune thrombocytopenia?. American journal of hematology. 2010 Letter GET IT
New thrombopoietic agents: introduction. Seminars in hematology. 2010 Editorial Article GET IT
Times cited: 5
Thrombopoietic agents in immune thrombocytopenia. Seminars in hematology. 2010 Review GET IT
Times cited: 17
Novel 47.5-kb deletion in RAB27A results in severe Griscelli Syndrome Type 2. 2010 GET IT
Times cited: 9
Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. American journal of obstetrics and gynecology. 2010 Academic Article GET IT
Times cited: 73
Diagnosis and management of chronic ITP: comments from an ICIS expert group. Annals of hematology. 2010 Review GET IT
Times cited: 12
The long-term impact of rituximab for childhood immune thrombocytopenia. Current rheumatology reports. 2010 Review GET IT
Times cited: 27
Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura. British journal of haematology. 2010 Academic Article GET IT
Times cited: 25
6th International Immunoglobulin Symposium: poster presentations. Clinical and experimental immunology. 2009 Academic Article GET IT
Times cited: 10
Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999). 2009 Academic Article GET IT
Times cited: 39
Traditional and new approaches to the management of immune thrombocytopenia: issues of when and who to treat. Hematology/oncology clinics of North America. 2009 Review GET IT
Times cited: 7
Update on eltrombopag for ITP. Oncology (Williston Park, N.Y.). 2009 Comment GET IT
Times cited: 11
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura. British journal of haematology. 2009 Academic Article GET IT
Times cited: 84
International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2009 Conference Paper GET IT
Times cited: 1483
Repeated courses of rituximab in chronic ITP: Three different regimens. American journal of hematology. 2009 Academic Article GET IT
Times cited: 61
Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood. 2009 Academic Article GET IT
Times cited: 157
Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. Journal of thrombosis and haemostasis : JTH. 2009 Review GET IT
Times cited: 58
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nature immunology. 2009 Academic Article GET IT
Times cited: 320
Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies. American journal of perinatology. 2009 Academic Article GET IT
Times cited: 9
Cytomegalovirus can make immune thrombocytopenic purpura refractory. 2009 GET IT
Times cited: 69
The ITP syndrome: pathogenic and clinical diversity. Blood. 2009 Review GET IT
Times cited: 584
Romiplostim: a second-generation thrombopoietin agonist. Drugs of today (Barcelona, Spain : 1998). 2009 Review GET IT
Times cited: 18
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2009 Academic Article GET IT
Times cited: 440
Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Seminars in perinatology. 2009 Review GET IT
Times cited: 72
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab. Pediatric blood & cancer. 2009 Academic Article GET IT
Times cited: 48
The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. Seminars in hematology. 2009 Conference Paper GET IT
Times cited: 25
Therapeutic approaches to secondary immune thrombocytopenic purpura. Seminars in hematology. 2009 Review GET IT
Times cited: 11
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood. 2008 Academic Article GET IT
Times cited: 200
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2008 Conference Paper GET IT
Times cited: 1881
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood. 2008 Academic Article GET IT
Times cited: 379
The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia. Current opinion in oncology. 2008 Review GET IT
Times cited: 15
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2008 Review GET IT
Times cited: 253
Refractory immune thrombocytopenic purpura: current strategies for investigation and management. British journal of haematology. 2008 Review GET IT
Times cited: 66
Memory B cells and pneumococcal antibody after splenectomy. Journal of immunology (Baltimore, Md. : 1950). 2008 Academic Article GET IT
Times cited: 62
Fc receptors in immune thrombocytopenias: a target for immunomodulation?. The Journal of clinical investigation. 2008 Comment GET IT
Times cited: 23
How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?. Nature clinical practice. Gastroenterology & hepatology. 2008 Comment GET IT
Times cited: 2
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood. 2008 Academic Article GET IT
Times cited: 190
The effect of anti-CD40 ligand in immune thrombocytopenic purpura. British journal of haematology. 2008 Academic Article GET IT
Times cited: 62
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health and quality of life outcomes. 2008 Academic Article GET IT
Times cited: 76
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet (London, England). 2008 Academic Article GET IT
Times cited: 710
Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura. Current opinion in pediatrics. 2008 Review GET IT
Times cited: 26
Overview of thrombopoietic agents in the treatment of thrombocytopenia. Clinical lymphoma & myeloma. 2008 Review GET IT
Times cited: 6
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. American journal of hematology. 2008 Academic Article GET IT
Times cited: 114
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 659
Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood reviews. 2007 Academic Article GET IT
Times cited: 77
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. The Journal of allergy and clinical immunology. 2007 Academic Article GET IT
Times cited: 134
Immune thrombocytopenic purpura in adults. Current opinion in hematology. 2007 Review GET IT
Times cited: 67
New therapies for immune thrombocytopenic purpura. Current opinion in hematology. 2007 Review GET IT
Times cited: 13
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). Blood. 2007 Academic Article GET IT
Times cited: 83
Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial. Obstetrics and gynecology. 2007 Academic Article GET IT
Times cited: 59
Immune thrombocytopenic purpura. Hematology/oncology clinics of North America. 2007 Review GET IT
Times cited: 66
A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP). Blood. 2007 Letter GET IT
Times cited: 21
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. The Journal of experimental medicine. 2007 Academic Article GET IT
Times cited: 109
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. British journal of haematology. 2007 Academic Article GET IT
Times cited: 130
A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clinical therapeutics. 2007 Academic Article GET IT
Times cited: 32
Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison. American journal of hematology. 2007 Academic Article GET IT
Times cited: 14
Novel thrombopoietic agents: preliminary activity, potential benefit. The journal of supportive oncology. 2007 Review GET IT
Times cited: 1
Treatment with rituximab in benign and malignant hematologic disorders in children. The Journal of pediatrics. 2007 Review GET IT
Times cited: 57
Update on therapeutic monoclonal antibodies. Current problems in pediatric and adolescent health care. 2007 Review GET IT
Times cited: 10
Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura. American journal of hematology. 2007 Academic Article GET IT
Times cited: 8
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health and quality of life outcomes. 2007 Academic Article GET IT
Times cited: 49
Advances in the management of alloimmune thrombocytopenia. British journal of haematology. 2007 Review GET IT
Times cited: 56
Identifying babies with neonatal alloimmune thrombocytopenia and the responsible antigens. Transfusion. 2007 Editorial Article GET IT
Times cited: 3
Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children. American journal of perinatology. 2006 Academic Article GET IT
Times cited: 30
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. The New England journal of medicine. 2006 Academic Article GET IT
Times cited: 462
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?. Blood. 2006 Academic Article GET IT
Times cited: 75
Alloimmune thrombocytopenia: state of the art 2006. American journal of obstetrics and gynecology. 2006 Review GET IT
Times cited: 48
Review of therapies for immune thrombocytopenic purpura. Seminars in hematology. 2006 Review GET IT
Times cited: 2
Treatment of immune thrombocytopenic purpura in adults. Seminars in hematology. 2006 Review GET IT
Times cited: 52
The pathogenesis of immune thrombocytopaenic purpura. British journal of haematology. 2006 Review GET IT
Times cited: 214
Correction of a murine model of von Willebrand disease by gene transfer. Blood. 2006 Academic Article GET IT
Times cited: 27
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura. American journal of hematology. 2006 Academic Article GET IT
Times cited: 75
Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstetrics and gynecology. 2006 Academic Article GET IT
Times cited: 100
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood. 2005 Academic Article GET IT
Times cited: 192
Prognostic relevance of large-platelet counts in patients with immune thrombocytopenic purpura. Haematologica. 2005 Letter GET IT
Times cited: 9
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatric blood & cancer. 2005 Academic Article GET IT
Times cited: 107
How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005 Review GET IT
Times cited: 287
Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP). American journal of hematology. 2005 Academic Article GET IT
Times cited: 42
Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. The Journal of pediatrics. 2005 Academic Article GET IT
Times cited: 124
Fetal and neonatal alloimmune thrombocytopenia in pregnancies involving in vitro fertilization: a report of four cases. 2005 GET IT
Times cited: 23
Differential diagnosis and management of thrombocytopenia in childhood. Pediatric clinics of North America. 2004 Review GET IT
Times cited: 25
Immune thrombocytopenic purpura: investigation of the role of cytomegalovirus infection. British journal of haematology. 2004 Letter GET IT
Times cited: 15
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. American journal of hematology. 2004 Academic Article GET IT
Times cited: 179
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life. Thrombosis and haemostasis. 2004 Academic Article GET IT
Times cited: 52
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. British journal of haematology. 2004 Academic Article GET IT
Times cited: 305
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms. British journal of haematology. 2004 Academic Article GET IT
Times cited: 84
The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. 2004 GET IT
Times cited: 32
Congenital and acquired thrombocytopenia. Hematology. American Society of Hematology. Education Program. 2004 Review GET IT
Times cited: 104
Fetal and neonatal cytopenias: what have we learned?. American journal of perinatology. 2003 Review GET IT
Times cited: 8
Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. British journal of haematology. 2003 Academic Article GET IT
Times cited: 65
T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy. Clinical and experimental immunology. 2003 Academic Article GET IT
Times cited: 23
Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?. Blood. 2003 Academic Article GET IT
Times cited: 137
Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatment. Platelets. 2003 Academic Article GET IT
Times cited: 3
Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. Journal of pediatric hematology/oncology. 2003 Review GET IT
Times cited: 140
21. Immunohematologic disorders. The Journal of allergy and clinical immunology. 2003 Review GET IT
Times cited: 12
Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). American journal of hematology. 2003 Academic Article GET IT
Times cited: 138
Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. Journal of pediatric hematology/oncology. 2003 Academic Article GET IT
Times cited: 47
Another interaction of the FcR system with IVIG. Thrombosis and haemostasis. 2002 Comment GET IT
Times cited: 16
Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesis. 2002 GET IT
Times cited: 36
Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. The Pediatric infectious disease journal. 2002 Academic Article GET IT
Times cited: 45
High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpura. British journal of haematology. 2002 Academic Article GET IT
Times cited: 19
Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood. 2002 Academic Article GET IT
Times cited: 129
Fetal and neonatal thrombopoietin levels in alloimmune thrombocytopenia. Pediatric research. 2002 Academic Article GET IT
Times cited: 22
Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. British journal of haematology. 2002 Academic Article GET IT
Times cited: 34
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?. Blood. 2002 Academic Article GET IT
Times cited: 80
Novel approaches to refractory immune thrombocytopenic purpura. Blood reviews. 2002 Review GET IT
Times cited: 19
Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients. Clinical and experimental immunology. 2002 Academic Article GET IT
Times cited: 8
Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease. Cardiology. 2002 Academic Article GET IT
Times cited: 21
Functional properties of lymphocytes in idiopathic thrombocytopenic purpura. Human immunology. 2001 Academic Article GET IT
Times cited: 32
Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility. American journal of obstetrics and gynecology. 2001 Academic Article GET IT
Times cited: 29
Alloimmune thrombocytopenia in the fetus and newborn. Seminars in thrombosis and hemostasis. 2001 Review GET IT
Times cited: 46
Anti-HPA-3A induces severe neonatal alloimmune thrombocytopenia. The Journal of pediatrics. 2001 Academic Article GET IT
Times cited: 73
Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. Journal of clinical immunology. 2001 Academic Article GET IT
Times cited: 84
Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?. American journal of hematology. 2001 Academic Article GET IT
Times cited: 44
A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. British journal of haematology. 2001 Academic Article GET IT
Times cited: 130
A pilot study of rhuIL-11 treatment of refractory ITP. American journal of hematology. 2001 Academic Article GET IT
Times cited: 54
Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology. American Society of Hematology. Education Program. 2001 Review GET IT
Times cited: 87
Overview of idiopathic thrombocytopenic purpura: new approach to refractory patients. Seminars in oncology. 2000 Review GET IT
Times cited: 45
Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia. 2000 GET IT
Times cited: 26
Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology. Blood. 2000 Academic Article GET IT
Times cited: 69
Fc receptor blockade and immune thrombocytopenic purpura. Seminars in hematology. 2000 Review GET IT
Times cited: 95
Idiopathic immune thrombocytopenic purpura: an update. Seminars in hematology. 2000 Review GET IT
Times cited: 12
Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy. The Journal of pediatrics. 2000 Academic Article GET IT
Times cited: 13
Thrombocytopenia with absent radii: frequency of marrow megakaryocyte progenitors, proliferative characteristics, and megakaryocyte growth and development factor responsiveness. 2000 GET IT
Times cited: 23
Hematologic toxicity of sodium valproate. Journal of pediatric hematology/oncology. 2000 Review GET IT
Times cited: 172
Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura. Seminars in hematology. 2000 Academic Article GET IT
Times cited: 19
The potential for treatment of idiopathic thrombocytopenic purpura with anti-D to prevent splenectomy: a predictive cost analysis. Seminars in hematology. 2000 Academic Article GET IT
Times cited: 16
Alloimmune thrombocytopenia. Clinical obstetrics and gynecology. 1999 Review GET IT
Times cited: 19
Is it necessary to test patients with immune thrombocytopenic purpura (ITP) for seropositivity to HTLV-1?. American journal of hematology. 1999 Academic Article GET IT
Times cited: 6
Treatment of children with immune thrombocytopenic purpura: are we closer to resolving the dilemma?. The Journal of pediatrics. 1998 Editorial Article GET IT
Times cited: 7
The fetal and neonatal consequences of maternal alloimmune thrombocytopenia. Bailliere's clinical haematology. 1998 Review GET IT
Times cited: 37
Blue papules and macules in a newborn. 1998 GET IT
Times cited: 2
BRa (HPA-5b) incompatibility may cause thrombocytopenia in neonates of mothers with immune thrombocytopenic purpura. Journal of pediatric hematology/oncology. 1998 Academic Article GET IT
Times cited: 3
Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura. Seminars in hematology. 1998 Review GET IT
Times cited: 34
Recent advances in the treatment of idiopathic thrombocytopenic purpura: the anti-D clinical experience. Seminars in hematology. 1998 Review GET IT
Times cited: 7
Immune thrombocytopenia in pregnancy: autoimmune and alloimmune. Journal of reproductive immunology. 1997 Review GET IT
Times cited: 50
Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstetrics and gynecology. 1997 Academic Article GET IT
Times cited: 82
Maternal IVIG in neonatal alloimmune thrombocytopenia. British journal of haematology. 1997 Letter GET IT
Times cited: 14
Fetal alloimmune thrombocytopenia. The New England journal of medicine. 1997 Academic Article GET IT
Times cited: 229
Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood. 1997 Academic Article GET IT
Times cited: 286
Acute idiopathic thrombocytopenic purpura--management in childhood. Blood. 1997 Letter GET IT
Times cited: 13
Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel. 1997 GET IT
Times cited: 130
Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group. Journal of pediatric hematology/oncology. 1997 Academic Article GET IT
Times cited: 47
Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood. 1996 Academic Article GET IT
Times cited: 113
TTP following ITP in an HIV-positive boy. 1996 GET IT
Times cited: 9
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. 1996 GET IT
Times cited: 1470
Further insights into autoimmune thrombocytopenia in pregnancy. American journal of obstetrics and gynecology. 1996 Letter GET IT
Times cited: 7
Treatment of human immunodeficiency virus-related thrombocytopenia with intravenous anti-rhesus D immunoglobulin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1996 Letter GET IT
Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. American journal of obstetrics and gynecology. 1996 Academic Article GET IT
Times cited: 187
Antiplatelet antibody testing in thrombocytopenic pregnant women. American journal of obstetrics and gynecology. 1996 Academic Article GET IT
Times cited: 61
Fetal transfusion therapy. Obstetrical & gynecological survey. 1996 Review GET IT
Times cited: 6
Serum levels of GM-CSF are elevated in patients with thrombocytopenia. British journal of haematology. 1996 Academic Article GET IT
Times cited: 19
Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization. American journal of perinatology. 1996 Academic Article GET IT
Times cited: 7
Fetal alloimmune thrombocytopenia: consensus and controversy. The Journal of maternal-fetal medicine. 1996 Review GET IT
Times cited: 39
Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol. Journal of pediatric hematology/oncology. 1995 Academic Article GET IT
Times cited: 62
Fetal neonatal thrombocytopenia. Thrombosis and haemostasis. 1995 Review GET IT
Times cited: 7
Fetal and neonatal thrombocytopenia. Blood reviews. 1995 Review GET IT
Times cited: 20
Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. American journal of obstetrics and gynecology. 1995 Academic Article GET IT
Times cited: 134
Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. European journal of pediatrics. 1995 Review GET IT
Times cited: 40
Neonatal thrombocytopenia. 1995 GET IT
Times cited: 38
Uses of intravenous gammaglobulin in immune hematologic disease. Immunological investigations. 1995 Review GET IT
Times cited: 20
Lactic acidosis and renal enlargement at diagnosis and relapse of acute lymphoblastic leukemia. 1994 GET IT
Times cited: 27
Antenatal management of the thrombocytopenias. Clinics in perinatology. 1994 Review GET IT
Times cited: 18
Mortality in immune thrombocytopenic purpura: report of seven cases and consideration of prognostic indicators. American journal of hematology. 1994 Review GET IT
Times cited: 63
Type II congenital dyserythropoietic anemia in a patient with ectodermal dysplasia. Distinction from dyskeratosis congenita. 1994 GET IT
Times cited: 2
Accurate intrapartum estimation of fetal platelet count by fetal scalp samples smear. American journal of perinatology. 1994 Academic Article GET IT
Times cited: 22
Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. American journal of hematology. 1993 Academic Article GET IT
Times cited: 144
Human immune development: implications for congenital HIV infection. Annals of the New York Academy of Sciences. 1993 Review GET IT
Times cited: 6
New developments in the treatment of neutropenia. American journal of diseases of children (1960). 1993 Review GET IT
Times cited: 11
Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. The Journal of pediatrics. 1993 Academic Article GET IT
Times cited: 51
Coagulation disorders in children. Current opinion in pediatrics. 1993 Review GET IT
Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient. 1993 GET IT
Times cited: 50
Prenatal management of fetal alloimmune thrombocytopenia. Vox sanguinis. 1993 Editorial Article GET IT
Times cited: 24
Antenatal treatment of alloimmune thrombocytopenia. Obstetrics and gynecology. 1992 Letter GET IT
Times cited: 3
Familial thrombocytopenia with micromegakaryocytes: what is the defect in thrombopoiesis?. The American journal of pediatric hematology/oncology. 1992 Editorial Article GET IT
Antenatal treatment of alloimmune thrombocytopenia. Obstetrics and gynecology. 1992 Academic Article GET IT
Times cited: 126
Anti-D for the treatment of splenectomized patients with immune thrombocytopenic purpura. Blood. 1991 Letter GET IT
Times cited: 15
Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. 1991 GET IT
Times cited: 130
Anti-D Ig for treatment of immune thrombocytopenic purpura. Blood. 1991 Letter GET IT
Times cited: 4
Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. The Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH. Thrombosis and haemostasis. 1991 Review GET IT
Times cited: 90
High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?. Obstetrics and gynecology. 1991 Letter GET IT
Times cited: 2
Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood. 1991 Academic Article GET IT
Times cited: 193
Thrombocytopenia in pregnancy. Lancet (London, England). 1991 Letter GET IT
Times cited: 34
Favorable neurological outcome in 7 cases of perinatal intracranial hemorrhage due to immune thrombocytopenia. The American journal of pediatric hematology/oncology. 1991 Academic Article GET IT
Times cited: 29
High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis? 1990 GET IT
Times cited: 42
Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. The New England journal of medicine. 1990 Academic Article GET IT
Times cited: 157
Antenatal management of fetal alloimmune and autoimmune thrombocytopenia. Transfusion medicine reviews. 1990 Review GET IT
Times cited: 34
High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. The Journal of pediatrics. 1990 Academic Article GET IT
Times cited: 83
Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better. American journal of hematology. 1990 Academic Article GET IT
Times cited: 23
Human megakaryocytes. VII. Analysis of megakaryocytes for nuclear DNA content distribution in whole marrow cell suspensions by flow cytometry. Experimental hematology. 1990 Academic Article GET IT
Times cited: 8
Thrombocytopenia in newborns, infants, and children. Pediatric annals. 1990 Review GET IT
Times cited: 13
Autoimmune thrombocytopenic purpura. Hematology/oncology clinics of North America. 1990 Review GET IT
Times cited: 52
Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trial. Reviews of infectious diseases. 1990 Academic Article GET IT
Times cited: 30
Neonatal uses of intravenous immunoglobulin. The American journal of pediatric hematology/oncology. 1990 Review GET IT
Times cited: 5
Plasma exchange in idiopathic thrombocytopenic purpura. Current studies in hematology and blood transfusion. 1990 Review GET IT
Times cited: 5
Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary report. American journal of diseases of children (1960). 1989 Academic Article GET IT
Times cited: 36
The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura. Clinical immunology and immunopathology. 1989 Review GET IT
Times cited: 32
Modulation of Fc receptor clearance and antiplatelet antibodies as a consequence of intravenous immune globulin infusion in patients with immune thrombocytopenic purpura. The Journal of allergy and clinical immunology. 1989 Review GET IT
Times cited: 33
Intravenous infusions of gammaglobulin in adults with chronic refractory immune thrombocytopenic purpura. Blood. 1989 Letter GET IT
Times cited: 1
Antenatal treatment of fetal alloimmune cytopenias. Blut. 1989 Academic Article GET IT
Times cited: 5
Commentary on the management of autoimmune thrombocytopenia during pregnancy and in the neonatal period. Blut. 1989 Academic Article GET IT
Times cited: 5
Antenatal treatment of neonatal alloimmune thrombocytopenia. The New England journal of medicine. 1988 Academic Article GET IT
Times cited: 284
T cell antigen receptors in autoimmunity. 1988 GET IT
Times cited: 40
Management of infants of mothers with immune thrombocytopenic purpura. The Journal of pediatrics. 1988 Academic Article GET IT
Times cited: 7
Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood. 1988 Academic Article GET IT
Times cited: 87
Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulin. American journal of hematology. 1988 Academic Article GET IT
Times cited: 43
The in utero diagnosis and management of alloimmune thrombocytopenia. 1988 GET IT
Times cited: 17
Analysis of lymphocyte proliferative response subpopulations in very low birth weight infants and during the first 8 weeks of life. Pediatric research. 1988 Academic Article GET IT
Times cited: 27
Cost-effectiveness of splenectomy versus intravenous gamma globulin in treatment of chronic immune thrombocytopenic purpura in childhood. The Journal of pediatrics. 1988 Academic Article GET IT
Times cited: 31
Intravenous treatment with gamma-globulin of autoimmune neutropenia of infancy. The Journal of pediatrics. 1988 Academic Article GET IT
Times cited: 50
Acute obstructive pancreatitis secondary to a duodenal hematoma. 1988 GET IT
Times cited: 4
Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura. Transfusion. 1988 Academic Article GET IT
Times cited: 25
Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia. 1987 GET IT
Times cited: 59
Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence. Hematology/oncology clinics of North America. 1987 Review GET IT
Times cited: 8
Autoimmune neutropenia of childhood. Critical reviews in oncology/hematology. 1987 Review GET IT
Times cited: 14
Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature. Vox sanguinis. 1987 Review GET IT
Times cited: 106
Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody. The Journal of experimental medicine. 1986 Academic Article GET IT
Times cited: 135
Immunoglobulin therapy for autoimmune hemolytic anemia. The Journal of pediatrics. 1986 Letter GET IT
Times cited: 1
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. 1986 GET IT
Times cited: 303
Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence. 1986 GET IT
Times cited: 11
Correlation of in vitro antibody synthesis with the outcome of intravenous gamma-globulin treatment of chronic idiopathic thrombocytopenic purpura. Journal of clinical immunology. 1986 Academic Article GET IT
Times cited: 41
IgG2 deficiency in autoimmune cytopenias. Monographs in allergy. 1986 Academic Article GET IT
Times cited: 15
Intravenous immunoglobulin therapy for the treatment of idiopathic thrombocytopenic purpura. Progress in hemostasis and thrombosis. 1986 Review GET IT
Times cited: 18
Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin. Vox sanguinis. 1986 Academic Article GET IT
Times cited: 75
Lack of seroconversion to human T-cell lymphotropic virus, type III, after intravenous immune globulin. Transfusion. 1986 Letter GET IT
Times cited: 8
Therapy in cytopenia. Vox sanguinis. 1986 Academic Article GET IT
Times cited: 6
Total knee arthroplasty in hemophilia. The Journal of bone and joint surgery. American volume. 1985 Academic Article GET IT
Elevation of platelet associated antibody levels in patients with chronic idiopathic thrombocytopenic purpura expressing the B8 and/or DR3 allotypes. Tissue antigens. 1985 Academic Article GET IT
Times cited: 19
Management of idiopathic thrombocytopenic purpura in childhood. New York state journal of medicine. 1985 Academic Article GET IT
Times cited: 4
Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin. The Journal of pediatrics. 1985 Academic Article GET IT
Times cited: 90
Intravenous immune serum globulin in immune thrombocytopenia: clinical results and biochemical evaluation. Vox sanguinis. 1985 Academic Article GET IT
Times cited: 16
Intravenous usage of gammaglobulin: humoral immunodeficiency, immune thrombocytopenic purpura, and newer indications. Cancer investigation. 1985 Academic Article GET IT
Times cited: 13
Intravenous gammaglobulin in the treatment of humoral immunodeficiency disease and autoimmune hematologic disease. Rational drug therapy. 1984 Academic Article GET IT
Times cited: 3
Hemophilia, antihemophilic factor, and immune complexes. Annals of internal medicine. 1984 Letter GET IT
Modulation of mononuclear phagocyte system function and circulating immune complexes by lyophilized concentrates in patients with classic hemophilia. Clinical immunology and immunopathology. 1984 Academic Article GET IT
Times cited: 4
Modulation of mononuclear phagocyte function by intravenous gamma-globulin. Journal of immunology (Baltimore, Md. : 1950). 1984 Academic Article GET IT
Times cited: 173
A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia. 1984 GET IT
Times cited: 31
The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease. British journal of haematology. 1984 Review GET IT
Times cited: 112
Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. The Journal of pediatrics. 1983 Academic Article GET IT
Times cited: 101
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood. 1983 Academic Article GET IT
Times cited: 257
Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. 1983 GET IT
Times cited: 110
Circulating anticoagulants: physiologic and pathophysiologic. Hospital practice (Office ed.). 1983 Academic Article GET IT
Times cited: 4
Transient appearance of the lupus anticoagulant in three family members sharing the A11B35DR4 haplotype. 1983 GET IT
Times cited: 7

more ...

less ...

Background

education and training

M.D., Columbia University College of Physicians and Surgeons 1975
B.S., Yale University 1971

Contact

full name

James B Bussel

primary email

jbussel@med.cornell.edu

VIVO Weill Cornell Medical College

James B Bussel Professor Emeritus of Pediatrics

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email